Here are the latest quarterly results of MARKSANS PHARMA.. For more details, see the MARKSANS PHARMA. financial fact sheet and MARKSANS PHARMA. share price. For a sector overview, read our pharmaceuticals sector report.
| No. of Mths Qtr. Ending |
3
Jun-24* |
3
Sep-24* |
3
Dec-24* |
3
Mar-25* |
3
Jun-25* |
3
Sep-25* |
3
Dec-25* |
3
Mar-26* |
8-Qtr Chart Click to enlarge |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 5,906 | 6,419 | 6,818 | 7,085 | 6,200 | 7,204 | 7,544 | 8,561 | |
| Other income | Rs m | 149 | -1 | 361 | 153 | 56 | 216 | 201 | 352 | |
| Turnover | Rs m | 6,056 | 6,419 | 7,180 | 7,238 | 6,256 | 7,420 | 7,746 | 8,913 | |
| Expenses | Rs m | 4,622 | 4,951 | 5,513 | 5,815 | 5,199 | 5,759 | 5,937 | 6,607 | |
| Gross profit | Rs m | 1,284 | 1,468 | 1,305 | 1,269 | 1,001 | 1,445 | 1,607 | 1,954 | |
| Depreciation | Rs m | 204 | 195 | 207 | 227 | 231 | 269 | 243 | 243 | |
| Interest | Rs m | 29 | 26 | 27 | 34 | 61 | 58 | 59 | 63 | |
| Profit before tax | Rs m | 1,200 | 1,246 | 1,433 | 1,161 | 766 | 1,333 | 1,506 | 2,000 | |
| Tax | Rs m | 310 | 268 | 382 | 254 | 184 | 342 | 369 | 510 | |
| Profit after tax | Rs m | 891 | 978 | 1,051 | 907 | 582 | 991 | 1,137 | 1,490 | |
| Gross profit margin | % | 21.7 | 22.9 | 19.1 | 17.9 | 16.1 | 20.1 | 21.3 | 22.8 | |
| Effective tax rate | % | 25.8 | 21.5 | 26.7 | 21.9 | 24.0 | 25.6 | 24.5 | 25.5 | |
| Net profit margin | % | 15.1 | 15.2 | 15.4 | 12.8 | 9.4 | 13.8 | 15.1 | 17.4 | |
| Diluted EPS | Rs | 2.0 | 2.2 | 2.3 | 2.0 | 1.3 | 2.2 | 2.5 | 3.3 | |
| Diluted EPS (TTM) | Rs | 7.4 | 7.7 | 8.2 | 8.4 | 7.8 | 7.8 | 8.0 | 9.3 | |
Although the benchmark indices opened lower, they traded negative throughout the session and ultimately closed red.